Back to Search
Start Over
Cytogenetic remissions in high-risk myelodysplastic syndrome: Results in 124 patients treated with low-dose 5-aza-2 '-deoxycytidine (Decitabine), a DNA methylation inhibitor.
- Source :
- Blood, Vol. 96, no. 11, p. 546A-+ (2000)
- Publication Year :
- 2000
Details
- Database :
- OAIster
- Journal :
- Blood, Vol. 96, no. 11, p. 546A-+ (2000)
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1130548788
- Document Type :
- Electronic Resource